A new blood test for colon cancer developed by VolitionRx has been shown to detect 85 percent of colorectal cancer cases, according to a we are CentralPA.com report.
The test has also been shown to detect 50 percent of polyps. VolitionRx researchers hope to make the test available in Europe within the next two years.
More Articles on Gastroenterology:
Creating an IBD Collaborative System of Care: 6 Key Elements From Dr. Vera Denmark
AAAS Names Dr. Bishr Omary 2013 Fellow
Where Do Gastroenterologists Stand in ACO Participation? 4 Statistics
The test has also been shown to detect 50 percent of polyps. VolitionRx researchers hope to make the test available in Europe within the next two years.
More Articles on Gastroenterology:
Creating an IBD Collaborative System of Care: 6 Key Elements From Dr. Vera Denmark
AAAS Names Dr. Bishr Omary 2013 Fellow
Where Do Gastroenterologists Stand in ACO Participation? 4 Statistics